Citation Impact
Citing Papers
From Myocarditis to Cardiomyopathy: Mechanisms of Inflammation and Cell Death
1999
In Vivo Activation of the p53 Pathway by Small-Molecule Antagonists of MDM2
2004 StandoutScience
Predictors of Outcome in Patients With Suspected Myocarditis
2008
Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer
2009 Standout
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
Coxsackievirus Myocarditis: Interplay between Virus and Host in the Pathogenesis of Heart Disease
2006
Risk of Developing a Subsequent Nonmelanoma Skin Cancer in Patients With a History of Nonmelanoma Skin Cancer
2000
Basal cell carcinomas: attack of the hedgehog
2008 Standout
Risk of Subsequent Basal Cell Carcinoma and Squamous Cell Carcinoma of the Skin Among Patients With Prior Skin Cancer
1992
Incidence of Basal Cell and Squamous Cell Carcinomas in a Population Younger Than 40 Years
2005
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries
2021 Standout
Ventricular remodeling in active myocarditis
1999
Retinoic acid receptors: From molecular mechanisms to cancer therapy
2014
A new paradigm for human resuscitation research using intelligent devices
2008
The FGF family: biology, pathophysiology and therapy
2009 Standout
Cardiac Troponin T in Patients With Clinically Suspected Myocarditis
1997
The prognosis of primary and metastasising melanoma. An evaluation of the TNM classification in 2,495 patients
1992
Immunopathogenesis and treatment of myocarditis: The United States myocarditis treatment trial
1996
Therapeutic Drug Monitoring in Oncology
1987
Applying the principles of stem-cell biology to cancer
2003
Coxsackievirus B3-Induced Myocarditis
1998
Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II)
2007 Standout
Dose calculation of anticancer drugs: a review of the current practice and introduction of an alternative.
1996 Standout
The Spectrum of Dilated Cardiomyopathy: The Johns Hopkins Experience with 1,278 Patients
1999
Systemic administration of doxorubicin-containing liposomes in cancer patients: a phase I study
1989
New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
2008 Standout
Eosinophilic Heart: Marked Left Ventricular Wall Thickening and Myocardial Dysfunction Improving With Corticosteroid Therapy
2003
Temporary Mechanical Support with the BVS 5000 Assist Device During Treatment of Acute Myocarditis
1997
A prospective study of biopsy-proven myocarditis: prognostic relevance of clinical and aetiopathogenetic features at diagnosis
2007
Myocarditis in patients with clinical presentation of myocardial infarction and normal coronary angiograms
2001
Dilated cardiomyopathy
2010
Influence of tumour micro-environment heterogeneity on therapeutic response
2013 StandoutNature
A new American Joint Committee on Cancer staging system for cutaneous melanoma
2000
Giant Cell Myocarditis: Diagnosis and Treatment
2000
Circulating Endothelial Progenitor Cells Are Reduced in Peripheral Vascular Complications of Type 2 Diabetes Mellitus
2005
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009 Standout
Immunohistological diagnosis of myocarditis Potential role of sarcolemmal induction of the MHC and ICAM-1 in the detection of autoimmune mediated myocyte injury
1998
Cannabinoids for control of chemotherapy induced nausea and vomiting: quantitative systematic review
2001
Clinical implications of anti-heart autoantibodies in myocarditis and dilated cardiomyopathy
2008
Survival in biopsy-proven myocarditis: A long-term retrospective analysis of the histopathologic, clinical, and hemodynamic predictors
2006
Cardiovirulent Coxsackieviruses and the Decay-Accelerating Factor (CD55) Receptor
1998
Randomized study on the efficacy of immunosuppressive therapy in patients with virus-negative inflammatory cardiomyopathy: the TIMIC study
2009
A New Weapon for Attacking Tumor Blood Vessels
2008 StandoutNobel
Cardiovascular Magnetic Resonance in Myocarditis: A JACC White Paper
2009 Standout
A New Equation to Estimate Glomerular Filtration Rate
2009 Standout
Clinical and Demographic Predictors of Outcomes in Recent Onset Dilated Cardiomyopathy
2011
Muronomab-CD3 for Pediatric Acute Myocarditis
2006
Routine Performance of Endomyocardial Biopsy Decreases the Incidence of Orthotopic Heart Transplant for Myocarditis
2009
Anticancer drug renal toxicity and elimination: dosing guidelines for altered renal function
1995
Imaging of the lymphatic system: new horizons
2006
Long-Term Results of a Multi-Institutional Randomized Trial Comparing Prognostic Factors and Surgical Results for Intermediate Thickness Melanomas (1.0 to 4.0 mm)
2000
Immunosuppressive therapy in acute myocarditis: an 18 year systematic review
2004
Resuscitation Outcomes Consortium (ROC) PRIMED cardiac arrest trial methods
2008
Recognition and Optimum Management of Myocarditis
1996
Viral causes of human myocarditis
2009
Angiogenesis in life, disease and medicine
2005 StandoutNature
Long-Term Outcome of Fulminant Myocarditis as Compared with Acute (Nonfulminant) Myocarditis
2000
Myocarditis
2011 Standout
Inhibition of coxsackievirus B3 carrier state infection of cultured human myocardial fibroblasts by ribavirin and human natural interferon-α
1997
Immunity, Inflammation, and Cancer
2010 Standout
Chemotherapy-Induced Nausea and Vomiting
2008 Standout
Identification and expansion of human colon-cancer-initiating cells
2006 StandoutNature
Therapeutic Angiogenesis in Peripheral Arterial Disease: Can Biotechnology Produce an Effective Collateral Circulation?
2004
Interobserver variability on the histopathologic diagnosis of cutaneous melanoma and other pigmented skin lesions.
1996
Management of the patient with progressive radioiodine non-responsive disease
1999
Echocardiographic findings in fulminant and acute myocarditis
2000
Gene transfer as a tool to induce therapeutic vascular growth
2003
Age as a prognostic factor in the malignant melanoma population
1994
Intravenous immune globulin in the therapy of peripartum cardiomyopathy
1999
Myocarditis and Heart Failure Associated With Hepatitis C Virus Infection
2006
Doxil® — The first FDA-approved nano-drug: Lessons learned
2012 Standout
Transplantation for Myocarditis: A Controversy Revisited
2005
Detection of myocarditis by contrast‐enhanced MRI in patients presenting with acute coronary syndrome but no coronary stenosis
2007
Myocarditis
2000 Standout
Myocardial Expression of Fas and Recovery of Left Ventricular Function in Patients With Recent-Onset Cardiomyopathy
2005
Immediate post-shock chest compressions improve outcome from prolonged ventricular fibrillation
2008
Mortality in Randomized Trials of Antioxidant Supplements for Primary and Secondary Prevention
2007 Standout
Greater symptom duration predicts response to immunomodulatory therapy in dilated cardiomyopathy
2007
Idiopathic Giant-Cell Myocarditis — Natural History and Treatment
1997
Cardiac Magnetic Resonance Appearance of Myocarditis Caused by High Dose IL-2: Similarities to Community-Acquired Myocarditis
2006
High‐dose intravenous immunoglobulin in the treatment of acute myocarditis. A case report and review of the literature
2002
Innovative Drug Treatments for Viral and Autoimmune Myocarditis
1998
Giant Cell and Granulomatous Myocarditis
2005
Oral nabilone capsules in the treatment of chemotherapy-induced nausea and vomiting and pain
2007
A comparison of two doses of adriamycin in the primary chemotherapy of disseminated breast carcinoma
1987
Use of Chemotherapy plus a Monoclonal Antibody against HER2 for Metastatic Breast Cancer That Overexpresses HER2
2001 Standout
Therapeutic use ofCannabis sativaon chemotherapy-induced nausea and vomiting among cancer patients: systematic review and meta-analysis
2008
Lone Hepatitis C Virus Myocarditis Responsive to Immunosuppressive Therapy
2002
Mortality in primary and secondary myocarditis
2004
Primary cutaneous melanoma. Optimized cutoff points of tumor thickness and importance of clark's level for prognostic classification
1995
The European Study of Epidemiology and Treatment of Cardiac Inflammatory Diseases (ESETCID)
2000
Oxygen Sensing, Homeostasis, and Disease
2011 StandoutNobel
The Role of Endomyocardial Biopsy in the Management of Cardiovascular Disease
2007
Identification of human brain tumour initiating cells
2004 StandoutNature
Influence of age on the prognostic importance of left ventricular dysfunction and congestive heart failure on long-term survival after acute myocardial infarction
1996
Vascular Growth in Ischemic Limbs: A Review of Mechanisms and Possible Therapeutic Stimulation
2008
Phase I study of direct administration of a replication deficient adenovirus vector containing the vascular endothelial growth factor cDNA (CI-1023) to patients with claudication
2002
Cancer-related inflammation
2008 StandoutNature
Molecular mechanisms and clinical applications of angiogenesis
2011 StandoutNature
Current Role of Endomyocardial Biopsy in the Management of Dilated Cardiomyopathy and Myocarditis
2001
Retinoids: present role and future potential
1999
Long-term follow-up of patients with complete remission following combination chemotherapy for metastatic breast cancer.
1996
Delaying Defibrillation to Give Basic Cardiopulmonary Resuscitation to Patients With Out-of-Hospital Ventricular Fibrillation
2003
Long-term outcome of acute myocarditis is independent of cardiac enzyme release
2003
Angiogenesis as a therapeutic target
2005 StandoutNature
Radical causes of cancer
2003
The Epidemiology of Childhood Cardiomyopathy in Australia
2003
The prognosis of patients with stage III melanoma prospective long-term study of 286 patients of the fachklinik hornheide
1993
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
Diagnostic Performance of Cardiovascular Magnetic Resonance in Patients With Suspected Acute Myocarditis
2005
Hypermutability and mismatch repair deficiency in RER+ tumor cells
1993 StandoutNobel
Myocarditis
2009 Standout
Prevention of non-melanoma skin cancer by targeting ultraviolet-B-light signalling
2003
Circulating cardiac autoantibodies in dilated cardiomyopathy and myocarditis: pathogenetic and clinical significance
2002
Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Taskforce
2006 Standout
Elevations of cardiac troponin I associated with myocarditis. Experimental and clinical correlates.
1997
Controlled Trial of Intravenous Immune Globulin in Recent-Onset Dilated Cardiomyopathy
2001
Prognostic factors in thin cutaneous malignant melanoma
1994
Randomized, Placebo-Controlled Study for Immunosuppressive Treatment of Inflammatory Dilated Cardiomyopathy
2001
ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult
2005 Standout
Dose: A critical factor in cancer chemotherapy
1980
Angiogenesis
2005
Myocarditis
2006 Standout
A multi-institutional Phase III study of nabilone vs. placebo in chemotherapy-induced nausea and vomiting
1982
The clinical significance of the morphological subdivision of diffuse "histiocytic" lymphoma: a study of 162 patients treated by the Southwest Oncology Group
1982
Nabilone: an alternative antiemetic for cancer chemotherapy.
1986
Expression of murine interleukin 7 in a murine glioma cell line results in reduced tumorigenicity in vivo.
1992 StandoutNobel
Favorable factors in the adjuvant therapy of breast cancer
1982
Acute doxorubicin toxicity relationship to pretreatment liver function, response, and pharmacokinetics in patients with acute nonlymphocytic leukemia
1984
ACC/AHA 2005 Practice Guidelines for the Management of Patients With Peripheral Arterial Disease (Lower Extremity, Renal, Mesenteric, and Abdominal Aortic)
2006 Standout
Structure of the STRA6 receptor for retinol uptake
2016 StandoutScienceNobel
Prognostic Factors Analysis of 17,600 Melanoma Patients: Validation of the American Joint Committee on Cancer Melanoma Staging System
2001 Standout
Myocarditis mimicking acute myocardial infarction: role of endomyocardial biopsy in the differential diagnosis
2000
Use of a Constitutively Active Hypoxia-Inducible Factor-1α Transgene as a Therapeutic Strategy in No-Option Critical Limb Ischemia Patients
2007
Treatment of viral myocarditis with focus on captopril
1996
Predicting ten-year survival of patients with primary cutaneous melanoma: corroboration of a prognostic model.
1997
Histologic and Cytokine Response to Immunosuppression in Giant-Cell Myocarditis
1998
Predicting ten-year survival of patients with primary cutaneous melanoma
1997
Active versus borderline myocarditis: clinicopathological correlates and prognostic implications
2002
Constitutively active HIF-1α improves perfusion and arterial remodeling in an endovascular model of limb ischemia
2005 StandoutNobel
Gender Differences in UVB-Induced Skin Carcinogenesis, Inflammation, and DNA Damage
2007
Molecular analysis of a chromosomal translocation, t(9;14)(p13;q32), in a diffuse large-cell lymphoma cell line expressing the Ki-1 antigen.
1990 StandoutNobel
Molecular Biology and Pathogenesis of Viral Myocarditis
2008
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009
ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death
2006
Breslow thickness and Clark level in melanoma
2000
Transcriptomic Biomarkers for the Accurate Diagnosis of Myocarditis
2011
Potential applications of therapeutic drug monitoring in treatment of neoplastic disease by antineoplastic agents
1986
Intravenous Immune Globulin in the Therapy of Myocarditis and Acute Cardiomyopathy
1997
The importance of dose intensity in chemotherapy of metastatic breast cancer.
1984 Standout
Antiemetics in Patients Receiving Chemotherapy for Cancer
1980
Breslow thickness and clark level in melanoma: support for including level in pathology reports and in American Joint Committee on Cancer Staging.
2000
Experience with the use of adriamycin in combination with other anticancer agents using a weekly schedule, with particular reference to lack of cardiac toxicity
1977
Prediction of Response to Cancer Chemotherapy
1983
Control of skin cancer by the circadian rhythm
2011 StandoutNobel
cis -Diammine(pyridine)chloroplatinum(II), a monofunctional platinum(II) antitumor agent: Uptake, structure, function, and prospects
2008 StandoutNobel
Elevations of Cardiac Troponin I Associated With Myocarditis
1997
The VIVA Trial
2003
Cutaneous malignant melanoma in southern Sweden 1965, 1975, and 1985
1997
Q Wave and Non-Q Wave Myocarditis with Special Reference to Clinical Significance.
1998
Mechanical circulatory support for the treatment of children with acute fulminant myocarditis
2001
Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay.
1988 Standout
Predictors of Disease Course in Patients With Acute Myocarditis
2000
Diagnosis of Myocarditis
2006
Inhibition of human ovarian cancer colony formation by adriamycin and its major metabolites.
1980
The Immune System in Viral Myocarditis
1999
Cannabinoids for Medical Use
2015 Standout
Lethal mitochondrial cardiomyopathy in a hypomorphic Med30 mouse mutant is ameliorated by ketogenic diet
2011 StandoutNobel
Regional Angiogenesis With Vascular Endothelial Growth Factor in Peripheral Arterial Disease
2003
Delta-9-Tetrahydrocannabinol as an Antiemetic for Patients Receiving Cancer Chemotherapy
1979
The Biology of Cancer Invasion and Metastasis
1978
Crossover comparison of the antiemetic efficacy of nabilone and alizapride in patients with nonseminomatous testicular cancer receiving cisplatin therapy
1986
HFSA guidelines for management of patients with heart failure caused by left ventricular systolic dysfunction—pharmacological approaches
1999
Neural Computing in Cancer Drug Development: Predicting Mechanism of Action
1992 StandoutScienceNobel
Fulminant Eosinophilic Myocarditis Associated With Visceral Larva Migrans Caused by Toxocara Canis Infection
2009
Synergistic effect of HIF-1α gene therapy and HIF-1-activated bone marrow-derived angiogenic cells in a mouse model of limb ischemia
2009 StandoutNobel
The Role of Endomyocardial Biopsy in the Management of Cardiovascular Disease
2007
Adenoviral transfer of HIF-1α enhances vascular responses to critical limb ischemia in diabetic mice
2009 StandoutNobel
Anti-emetic efficacy and toxicity of nabilone, a synthetic cannabinoid, in lung cancer chemotherapy
1983
Immunosuppressive Therapy for Active Lymphocytic Myocarditis
2003
The Anthracycline Antineoplastic Drugs
1981 Standout
Secretion of Angiogenic and Antiapoptotic Factors by Human Adipose Stromal Cells
2004 Standout
Advances in the Understanding of Myocarditis
2001
Therapeutic Angiogenesis and Vasculogenesis for Ischemic Disease
2004
Part 14: Pediatric Advanced Life Support
2010 Standout
Heterogeneity of malignant cells from a human colonic carcinoma.
1981
Unstable Methotrexate Resistance in Human Small-Cell Carcinoma Associated with Double Minute Chromosomes
1983
Contrast Media–Enhanced Magnetic Resonance Imaging Visualizes Myocardial Changes in the Course of Viral Myocarditis
1998
Comparative Evaluation of Left and Right Ventricular Endomyocardial Biopsy
2010
Long-term follow up of patients with dilated heart muscle disease treated with human leucocytic interferon alpha or thymic hormones initial results.
1996
DHFR/MSH3 amplification in methotrexate-resistant cells alters the hMutSα/hMutSβ ratio and reduces the efficiency of base–base mismatch repair
1997 StandoutNobel
Drug Prescribing in Renal Failure: Dosing Guidelines for Adults.
1988
ATP-sensitive potassium channel (K ATP )–dependent regulation of cardiotropic viral infections
2011 StandoutNobel
Works of Thomas E. Moon being referenced
Predictors for cutaneous basal- and squamous-cell carcinoma among actinically damaged adults
2001
Effect of retinol in preventing squamous cell skin cancer in moderate-risk subjects: a randomized, double-blind, controlled trial. Southwest Skin Cancer Prevention Study Group.
1997
Trends in the incidence of nonmelanoma skin cancers in southeastern Arizona, 1985-1996
2001
Trial of retinol and isotretinoin in skin cancer prevention: a randomized, double-blind, controlled trial. Southwest Skin Cancer Prevention Study Group.
1997
The Myocarditis Treatment Trial: design, methods and patient enrolment
1995
Enhancement of Regression of Cervical Intraepithelial Neoplasia II (Moderate Dysplasia) With Topically Applied All- trans -Retinoic Acid: a Randomized Trial
1994
A Clinical Trial of Immunosuppressive Therapy for Myocarditis
1995
The risk of developing subsequent nonmelanoma skin cancers
1990
Design of the therapeutic angiogenesis with recombinant fibroblast growth factor-2 for intermittent claudication (TRAFFIC) trial
2001
Cutaneous malignant melanoma. II. The natural history and prognostic factors influencing the development of stage II disease
1989
Age-related prognosis after acute myocardial infarction (The multicenter diltiazem postinfarction trial)
1990
Cutaneous malignant melanoma (arizona cancer center experience). I. Natural history and prognostic factors influencing survival in patients with stage i disease
1988
Retinoids in prevention of skin cancer
1997
Oral melphalan kinetics
1979
Dose response evaluation of adriamycin in human neoplasia
1977
Clinical Correlations of Drug Sensitivity in the Human Tumor Stem Cell Assay
1980
Superiority of Nabilone over Prochlorperazine as an Antiemetic in Patients Receiving Cancer Chemotherapy
1979
Quantitation of Differential Sensitivity of Human-Tumor Stem Cells to Anticancer Drugs
1978
Influence of time and therapy on ventricular defibrillation in dogs
1980
Prediction of outcome in metastatic breast cancer treated with adriamycin combination chemotherapy
1980
Hydroxyldaunomycin (adriamycin) combination chemotherapy in malignant lymphoma
1976
Kinetics of intravenous melphalan
1979
Histopathologic review of lymphoma cases from the southwest oncology group
1977
The role of lymphangiography in vulvar carcinoma
1986
Double-blind crossover study of the antiemetic efficacy of high-dose dexamethasone versus high-dose metoclopramide.
1984
Lymphatic metastasis with childhood rhabdomyosarcoma
1977
Bleomycin pharmacokinetics in man
1979
Therapeutic angiogenesis with recombinant fibroblast growth factor-2 for intermittent claudication (the TRAFFIC study): a randomised trial
2002
Superiority of adriamycin-containing combination chemotherapy in the treatment of diffuse lymphoma.A southwest oncology group study
1979
Bleomycin pharmacokinetics in man
1978
Nabilone: a potent antiemetic cannabinol with minimal euphoria.
1977
Pharmacological Treatment of Coronary Artery Disease With Recombinant Fibroblast Growth Factor-2
2002